Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer–Mediated Cytotoxicity
Antoun Al Absi, Hannah Wurzer, Coralie L. Guérin, et al.
Cancer Research (2018) Vol. 78, Iss. 19, pp. 5631-5643
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Natural killer cells in cancer biology and therapy
Song‐Yang Wu, Tong‐Ming Fu, Yi‐Zhou Jiang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 621
Targeting immune cells for cancer therapy
Sin Yee Gun, Sharon Wei Ling Lee, Je Lin Sieow, et al.
Redox Biology (2019) Vol. 25, pp. 101174-101174
Open Access | Times Cited: 206
Rho GTPase signaling in cancer progression and dissemination
Eva Crosas‐Molist, Rémi Samain, Leonie Kohlhammer, et al.
Physiological Reviews (2021) Vol. 102, Iss. 1, pp. 455-510
Open Access | Times Cited: 164
Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
Arpita Datta, Shuo Deng, Vennila Gopal, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1882-1882
Open Access | Times Cited: 122
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 49
Cell–cell interfaces as specialized compartments directing cell function
Brian Belardi, Sungmin Son, James H. Felce, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 12, pp. 750-764
Closed Access | Times Cited: 108
Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer
Christian Sordo‐Bahamonde, Seila Lorenzo‐Herrero, Ángel Ramírez Páyer, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3726-3726
Open Access | Times Cited: 90
Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer
Molly A. Nelson, Worapol Ngamcherdtrakul, Shiuh‐Wen Luoh, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 2, pp. 519-536
Open Access | Times Cited: 88
Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy
Raefa Abou Khouzam, Goutham Hassan Venkatesh, Rania F. Zaarour, et al.
Seminars in Cancer Biology (2020) Vol. 65, pp. 140-154
Open Access | Times Cited: 81
Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity
Karoliina Tuomela, Ashley Ambrose, Daniel M. Davis
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer
Mona M. Elanany, Dina Mostafa, Nadia Μ. Hamdy
Life Sciences (2023) Vol. 330, pp. 121997-121997
Closed Access | Times Cited: 32
AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
Stéphane Terry, Abdérémane Abdou, Agnete S.T. Engelsen, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 11, pp. 1789-1802
Open Access | Times Cited: 70
Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer
Deli Mao, Zhijun Zhou, Hengxing Chen, et al.
Cancer Letters (2023) Vol. 572, pp. 216351-216351
Open Access | Times Cited: 18
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Actin Cytoskeleton Straddling the Immunological Synapse between Cytotoxic Lymphocytes and Cancer Cells
Hannah Wurzer, Céline Hoffmann, Antoun Al Absi, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 463-463
Open Access | Times Cited: 54
Focus on Cdc42 in Breast Cancer: New Insights, Target Therapy Development and Non-Coding RNAs
Yu Zhang, Jun Li, Xing-Ning Lai, et al.
Cells (2019) Vol. 8, Iss. 2, pp. 146-146
Open Access | Times Cited: 47
Nup93 regulates breast tumor growth by modulating cell proliferation and actin cytoskeleton remodeling
Simone Bersini, Nikki K. Lytle, Roberta Schulte, et al.
Life Science Alliance (2020) Vol. 3, Iss. 1, pp. e201900623-e201900623
Open Access | Times Cited: 47
Metastatic Colonization: Escaping Immune Surveillance
Julien Schaller, Judith Agudo
Cancers (2020) Vol. 12, Iss. 11, pp. 3385-3385
Open Access | Times Cited: 41
The Significant Role of the Microfilament System in Tumors
Xin Jiang, Yiming Qin, Kun Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 40
The Role of the Cytoskeleton in Regulating the Natural Killer Cell Immune Response in Health and Disease: From Signaling Dynamics to Function
Aviad Ben‐Shmuel, Batel Sabag, Guy Biber, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 35
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
Barbara Seliger, Ulrike Koehl
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Human NK cells and cancer
Claudia Cantoni, Michela Falco, Massimo Vitale, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
ELK3-CYFIP2 axis-mediated actin remodeling modulates metastasis and natural killer cell responses in triple-negative breast cancer
Seung Hee Choi, Hye Jung Jang, Joo Dong Park, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Epithelial‐mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1
Baoguang Hu, Xiaokun Tian, Yanbin Li, et al.
Cancer Medicine (2020) Vol. 9, Iss. 8, pp. 2686-2697
Open Access | Times Cited: 37
The Tumor Microenvironment—A Metabolic Obstacle to NK Cells’ Activity
J Domagała, Mieszko Lachota, Marta Kłopotowska, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3542-3542
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top